Table 3. Antibiotic therapy for necrotizing fasciitis.
Disease classification | Antibiotic | Adult dose |
---|---|---|
Empirical therapy | Teicoplanin or | 6–12 mg/kg q24 h IV |
vancomycin or | 15 mg/kg q12 h IV | |
linezolid | 600 mg q12 h IV | |
plus | ||
piperacillin/tazobactam or | 3.375–4.5 g q8 h IV | |
ertapenem or | 1 g q24 h IV | |
meropenem or | 1 g q8 h IV | |
imipenem or | 500 mg q6 h IV | |
cefepime | 2 g q8 h IV | |
plus | ||
metronidazole | 500 mg q8 h IV | |
Streptococcus | Penicillin | 2–4 million units q4–6 h IV |
plus | ||
clindamycin | 600–900 mg q8 h IV | |
Methicillin-susceptible Staphylococcus aureus | Nafcillin or | 1–2 g q4 h IV |
cefazolin | 1–2 g q8 h IV | |
Methicillin-resistant Staphylococcus aureus | Vancomycin or | 15 mg/kg q12 hr IV |
teicoplanin or | 6–12 mg/kg q24 h IV | |
linezolid | 600 mg q12 h IV | |
Aeromonas hydrophilia | Ciprofloxacin or | 400 mg q12 h IV |
cefotaxime or | 2 g q8 h IV | |
ceftriaxone | 2 g q24 h IV | |
plus | ||
doxycycline | 100 mg bid PO | |
Vibrio vulnificus | Cefotaxime or | 2 g q8 h IV |
ceftriaxone | 2 g q24 h IV | |
plus | ||
doxycycline | 100 mg bid PO |
IV, intravenous; PO, per os.